The Physiology and Pharmacology Group is comprised of a multidisciplinary team of researchers studying the underlying physiology of some of the most important eye diseases in our community.
Many of the techniques established are unique to the group, requiring a combination of technical skill and novelty of approach. Based on the results obtained from more than 35 years of basic research there are now several new avenues of clinical therapy that are being investigated.
These include improved techniques for laser treatment of ischemic retinal diseases such as diabetic retinopathy, new surgical approaches to glaucoma surgery, robotic surgery systems, and pharmacological approaches to restoring normal blood flow. This is in addition to our studies of the physiology of the retina in health and disease.